This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup?
SCAI celebrated cardiologists William W. O'Neill, MD, and Cindy L. Grines, MD, for the important roles they played in the development of primary PCI. “It was challenging,” Grines explained. “We had the pharmaceutical industry that was anti-primary angioplasty and we had a lot of our own colleagues that were anti-primary angioplasty."
Self-expanding and balloon-expandable TAVR valves are associated with comparable success rates and one-year outcomes when treating type 1 bicuspid aortic stenosis. However, each valve type comes with its own advantages and disadvantages.
Healthcare CFOs spend more time dealing with cost management and, by extension, operational issues than any other single set of items on their to-do lists.
“Applause broke out in the OR. It was quite an amazing experience,” recalls Winfred Williams, MD, associate professor of medicine at MGH and Slayman’s nephrologist, referring to the moment the kidney “immediately pinked up” during implantation.
Imperfect algorithms. Resistant clinicians. Wary patients. Divisive disparities. The plot ingredients of a flashy techno-thriller coming to a cineplex near you? No—just a few of the many worries that provider organizations take on when they move to adopt AI at scale.